Inhibition of PI3K/AKT/GLUT1 Signaling Pathway by Quercetin in the Treatment of Psoriasis
Through <i>in vivo</i> and <i>in vitro</i> experiments, this study shows that quercetin may play a therapeutic role in psoriasis and inhibit the PI3K/AKT/GLUT1 signaling pathway.
Authors
- Doudou Wu (ORCID: https://orcid.org/0000-0002-9288-7678)
- Jie Ma (ORCID: https://orcid.org/0000-0001-6079-9342)
- Ying Wang (ORCID: https://orcid.org/0000-0002-9636-6300)
- Feifei Wang (ORCID: https://orcid.org/0000-0002-2351-6873)
- Nuo Li (ORCID: https://orcid.org/0000-0003-1106-8783)
- Yanping Bai (ORCID: https://orcid.org/0000-0002-7754-9283)
- Wei Jiang (ORCID: https://orcid.org/0000-0001-9361-3444)
- Lei Wang (ORCID: https://orcid.org/0000-0003-0734-7026)
Institutions
- Beijing University of Chinese Medicine (CN)
- China-Japan Friendship Hospital (CN)
- Shunyi Hospital of Beijing Traditional Chinese Medicine Hospital (CN)
- Beijing Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Bioscience-Landmark
- Published
- 2025-02-21
- DOI
- https://doi.org/10.31083/fbl26884
- Citations
- 3
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 2.39
Funders
- National Natural Science Foundation of China